SalioGen Therapeutics
Drug Discovery
SalioGen Therapeutics valuation and funding history | Last updated: May 1, 2022 | 1 funding rounds
Current Valuation
N/A
As of May 1, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$132.3M
Last Funding
May 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| May 1, 2022 | Early Stage VC (Series B) | $132.3M | N/A | - |
Valuation Analysis
Current Valuation Metrics
SalioGen Therapeutics is currently valued at N/A as of May 1, 2022.
Explore More Data
Detailed analysis for SalioGen Therapeutics
What is SalioGen Therapeutics Worth in 2026?
SalioGen Therapeutics is a leading private company in the Drug Discovery sector. Track SalioGen Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How SalioGen Therapeutics Valuation is Determined
Private company valuations like SalioGen Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.